Additionally, the upstream factor Triggering receptor expressed on myeloid cells 2 (TREM2) has been shown to potently activate Foxo3a within the AD brain tissues via the transduction of PI3K/AKT signaling (Wang Y. et al., 2020). The gene discussed is AKT1; the disease is Alzheimer disease.